http://www.aidsmap.com/CROI-2013-bulletins/page/2571835/ en-gb NAM Publications - 2013 Fri, 22 Mar 2013 09:57:05 GMT Fri, 22 Mar 2013 09:57:05 GMT http://backend.userland.com/rss RSS.NET: http://www.rssdotnet.com/ Douglas Dieterich, Mt Sinai School of Medicine, New York. © Liz Highleyman / hivandhepatitis.com Several studies presented at the conference show that newer protease inhibitors for hepatitis C treatment perform well in people with HIV/HCV co-infection, and have fewer serious side-effects than currently available HCV protease inhibitors.Adding the investigational hepatitis C protease inhibitor http://www.aidsmap.com/Wednesday-13th-March-2013/page/2598809/ aidsmap.com http://www.aidsmap.com/page/2598809/ Wed, 13 Mar 2013 00:40:00 GMT Mutsa Bwakura-Dangarembizi presenting at CROI 2013.Continuing daily cotrimoxazole prophylaxis after starting HIV therapy has significant health benefits for children, according to the results of research conducted in Uganda and Zimbabwe. Prophylaxis with the antibiotic cotrimoxazole is recommended for people living with HIV who have a weakened immune system. The drug provides important protection against the http://www.aidsmap.com/Thursday-7th-March-2013/page/2591387/ aidsmap.com http://www.aidsmap.com/page/2591387/ Thu, 07 Mar 2013 00:40:00 GMT Matt Anderson at CROI 2013. © Liz Highleyman / hivandhepatitis.comMK-1439, a next generation non-nucleoside reverse transcriptase inhibitor has performed well in an early clinical trial. The drug had a powerful anti-HIV effect and was well-tolerated. The double-blind placebo controlled study involved 18 people with HIV who had not taken antiretroviral therapy before (treatment naive). http://www.aidsmap.com/Wednesday-6th-March-2013/page/2589362/ aidsmap.com http://www.aidsmap.com/page/2589362/ Wed, 06 Mar 2013 00:40:00 GMT Deborah Persaud from Johns Hopkins University School of Medicine at CROI 2013. © Liz Highleyman / hivandhepatitis.com.The 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) opened with the exciting news of the 'functional cure' of an HIV-infected infant. This was achieved using triple-drug antiretroviral therapy which was initiated within hours of birth. The child has now http://www.aidsmap.com/Tuesday-5th-March-2013/page/2587795/ aidsmap.com http://www.aidsmap.com/page/2587795/ Tue, 05 Mar 2013 00:40:00 GMT